ISOTRETINOIN MEDICATION PROGRAM: ALERTING YOU TO THE RISKS OF TERATOGENICITY (I.M.P.A.R.T.)

Serial Number 76516376
Registration 2836216
710

Registration Progress

Application Filed
May 22, 2003
Under Examination
Approved for Publication
Jan 14, 2004
Published for Opposition
Feb 3, 2004
Registered
Apr 27, 2004

Trademark Image

ISOTRETINOIN MEDICATION PROGRAM: ALERTING YOU TO THE RISKS OF TERATOGENICITY (I.M.P.A.R.T.)

Basic Information

Serial Number
76516376
Registration Number
2836216
Filing Date
May 22, 2003
Registration Date
April 27, 2004
Published for Opposition
February 3, 2004
Cancellation Date
December 3, 2010
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
710
Status Date
Dec 3, 2010

Rights Holder

RANBAXY LABORATORIES LIMITED

03
Address
19, Nehru Place
New Delhi, Delhi 110019
IN

Ownership History

RANBAXY LABORATORIES LIMITED

Original Applicant
03
New Delhi, Delhi IN

RANBAXY LABORATORIES LIMITED

Owner at Publication
03
New Delhi, Delhi IN

RANBAXY LABORATORIES LIMITED

Original Registrant
03
New Delhi, Delhi IN

Legal Representation

Attorney
Jayadeep R. Deshmukh

USPTO Deadlines

Next Deadline
3187 days remaining
Section 8 & 9 (30-Year) Renewal Due (Based on registration date 2004-04-27)
Due Date
April 27, 2034
Grace Period Ends
October 27, 2034

Application History

7 events
Date Code Type Description Documents
Dec 3, 2010 C8.. O CANCELLED SEC. 8 (6-YR) Loading...
Apr 27, 2004 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Feb 3, 2004 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 14, 2004 NPUB O NOTICE OF PUBLICATION Loading...
Dec 1, 2003 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 24, 2003 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 24, 2003 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...

Additional Information

Pseudo Mark
ISOTRETINOIN MEDICATION PROGRAM: ALERTING YOU TO THE RISKS OF TERATOGENICITY IMPART

Disclaimers

The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"ISOTRETINOIN MEDICATION PROGRAM: ALERTING YOU TO THE RISKS OF TERATOGENICITY"